Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Proffered paper session - Sarcoma

638 - Outcome following unplanned excision in soft tissue sarcoma. Results of a multicentre study including 728 patients.


19 Oct 2018


Proffered paper session - Sarcoma


Surgical Oncology

Tumour Site

Soft Tissue Sarcomas


Maria Smolle


Annals of Oncology (2018) 29 (suppl_8): viii576-viii595. 10.1093/annonc/mdy299


M.A. Smolle1, P. Tunn2, E. Goldenitsch3, F. Posch4, J. Szkandera4, M. Bergovec1, B. Liegl-Atzwanger5, A. Leithner1

Author affiliations

  • 1 Department Of Orthopaedics And Trauma, Medical University of Graz, 8036 - Graz/AT
  • 2 Sarcoma Centre, HELIOS Klinikum Berlin-Buch, Berlin/DE
  • 3 Sarcoma Care, Orthopaedic Hospital Gersthof, Vienna/AT
  • 4 Division Of Clinical Oncology, Medical University of Graz, Graz/AT
  • 5 Institute Of Pathology, Medical University of Graz, Graz/AT


Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract 638


Misdiagnosis of soft tissue sarcoma (STS) is common, due to their rarity and unclear clinical presentation. As a result, unplanned excisions (UE) may occur, most often necessitating further treatment at specialised tumour centres. Therapy includes re-resection and adjuvant radiotherapy (ARTX), being associated with increased morbidity. Results on UE’s impact on overall survival (OS) are contradictory, though.


728 STS patients (376 male, 352 female; mean age: 58 years) undergoing primary surgery or re-resection following UE at three tumour centres were retrospectively included. Median follow-up was 5.5 years. Differences between UE- and non-UE-patients were analysed using chi-square and t-tests. Log-rank and Gray’s tests were applied for time-to-event analyses. Based on differences between UE- and non-UE-patients at baseline, a propensity score of being in the UE-group was estimated. Based on the propensity score, an inverse-probability-of-UE-weight (IPUEW) was calculated. This allowed re-calculation of time-to-event analyses following adjustment for imbalances between non-UE- and UE-patients.


UE had been performed in 281 patients (38.6%), with similar incidences at the three tumour centres. Small (p < 0.005) and superficially located STS (p < 0.005) with a long history of symptoms (p < 0.005), male gender (p = 0.05) and young age (p = 0.036) raised the risk of an UE being performed. At re-resection, plastic reconstruction (p < 0.005) and ARTX (p = 0.041) were significantly more common in UE-patients. In the univariate analysis, UE-patients had a significantly better OS (5-/10-year OS: 78.6%/63.3% for UE; 70.6%/57.9% for non-UE; p = 0.028). Due to a strong correlation between positive prognostic factors and a prior UE, survival analyses were re-calculated after weighting for the IPUEW. As a result, the prognostic benefit of UE in terms of OS was lost (p = 0.241).


Morbidity is raised in patients following UE due to increased necessity of plastic reconstruction and ARTX. However, there is no direct impact of UE on OS. Nevertheless, it is arguable whether a more aggressive approach in the UE-group compensates for the inappropriate primary resection. Thus, UE must be avoided by all means.

Clinical trial identification

Legal entity responsible for the study

Medical University of Graz.


Has not received any funding.

Editorial Acknowledgement


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.